Abstract:Objective To detect the expression status of DNA topoisomerase Ⅱ alpha (DNA TopoⅡα) in craniopharyngioma tissues, analyze the relationship between DNA TopoⅡα expression and tumor recurrence, and determine whether DNA TopoⅡα may be a valuable index in judging the prognosis of craniopharyngiomas. Methods The prospective cohort study program was designed. The expression level of DNA TopoⅡα was investigated by immunohistochemical avidin-biotin-peroxidase complex (ABC) method in 63 cases of tissue sections of craniopharyngioma. The quantitative analysis for DNA TopoⅡα expression was performed by using TE2000-U inverted biological microscopy and Image-Pro Plus professional image analysis software. The proliferative potential of oncocytes was evaluated in matched groups, such as adamantine epitheliomas (AE) and squamous papillary tumors (SP), recurrence and recurrence-free groups, as well as primary and relapse groups.Results Fourteen of 32 cases of AE and 6 of 31 cases of SP recurred during follow-up period. There were significant differences on DNA TopoⅡα expression level both between AE and SP groups, and between recurrence and recurrence-free groups (P0.05, two-tailed), but there was not significant difference on DNA TopoⅡα expression level between primary and relapse groups (P0.05). Conclusion The pathological subtypes of craniopharyngiomas and DNA TopoⅡα expression level are related with the prognosis of craniopharyngiomas. There was not significant difference in DNA TopoⅡα expression level between primary and relapse groups, which indicates that the proliferative activity of craniopharyngioma cells has not changed during recurring process.

Expression of Integrin Αvβ3 in Craniopharyngioma and Its Correlation with Prognosis

Expression of CXCR4 in Craniopharyngiomas and Its Correlation with Prognosis

Expression of VEGF and MVD in Craniopharyngiomas and Correlation with the Prognosis of the Tumour

Research on the correlativity of expressions of CXCL12 and CXCR4 with the invasiveness and recurrence of adamantimous craniopharyngiomas

Recurrent Prognostic Factors And Expression Of Glut-1, Pi3k And P-Akt In Adenoid Cystic Carcinomas Of The Head And Neck: Clinicopathological Features And Biomarkers Of Adenoid Cystic Carcinoma

Microvascular Density And Vascular Endothelial Growth Factor Have Little Correlation With Prognosis Of Craniopharyngioma

Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.

Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.

Expression of Human MCM6 and DNA Topo II α in craniopharyngiomas and its correlation with recurrence of the tumor

Craniopharyngioma: Survivin Expression and Ultrastructure.

Relationship Between DNA Topoisomerase Ⅱ Alpha Expression and Prognosis in Craniopharyngiomas

[Expression of Minichromosome Maintenance Protein 6 in Craniopharyngioma and Its Correlation with Prognosis].

Expression and Significance of Apoptotie Suppressor Gene Survivin in Craniopharyngioma

The relationship between integrin αvβ3 and brain glioma's malignancy

The Study on the Expression of IFn-α and TGF-β1 in Different Types of Craniopharyngiomas

Expression of Interferon-Α Receptor and Proliferating Cell Nuclear Antigen in Craniopharyngioma

Epithelial-Mesenchymal Transition and Clinicopathological Correlation in Craniopharyngioma

Expression of Matrix Metalloproteinase-9, Type IV Collagen and Vascular Endothelial Growth Factor in Adamantinous Craniopharyngioma

Correlation Between the Matrix Metauoproteinase-a, Vascular Endothelial Growth Factor and the Invasion and Recurrence of Adamantinomatous Craniopharyngioma

Microvascular density and vascular endothelial growth factor have little correlation with prognosis of craniopharyngioma.

Relative Quantitative Expression Of Hypoxia-Inducible Factor 1 Alpha Messenger Ribonucleic Acid In Recurrent Craniopharyngiomas